Serviceeinschränkungen vom 12.-22.02.2026 - weitere Infos auf der UB-Homepage
  • Uptake of the HPV vaccination...

Treffer: Uptake of the HPV vaccination programme in England: a cross-sectional survey of young women attending sexual health services.

Title:
Uptake of the HPV vaccination programme in England: a cross-sectional survey of young women attending sexual health services.
Authors:
Sacks RJ; Jefferiss Wing, Imperial College Healthcare NHS Trust, London, UK., Copas AJ; Research Department of Infection & Population Health, University College London, London, UK., Wilkinson DM; Jefferiss Wing, Imperial College Healthcare NHS Trust, London, UK., Robinson AJ; Camden Provider Services, Central and North West London NHS Foundation Trust, London, UK.
Source:
Sexually transmitted infections [Sex Transm Infect] 2014 Jun; Vol. 90 (4), pp. 315-21. Date of Electronic Publication: 2014 Mar 17.
Publication Type:
Journal Article
Language:
English
Journal Info:
Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 9805554 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1472-3263 (Electronic) Linking ISSN: 13684973 NLM ISO Abbreviation: Sex Transm Infect Subsets: MEDLINE
Imprint Name(s):
Original Publication: London : BMJ Pub. Group, c1998-
MeSH Terms:
Immunization Programs/*statistics & numerical data , Papillomavirus Infections/*prevention & control , Papillomavirus Vaccines/*therapeutic use , Uterine Cervical Neoplasms/*prevention & control, Adolescent ; Cross-Sectional Studies ; Educational Status ; England/epidemiology ; Female ; Health Services ; Humans ; Logistic Models ; London/epidemiology ; Mass Vaccination ; Multivariate Analysis ; Reproductive Health ; Risk Factors ; Sexually Transmitted Diseases/epidemiology ; Smoking/epidemiology ; Surveys and Questionnaires ; Uterine Cervical Neoplasms/virology ; Young Adult
Comments:
Comment in: BMJ. 2014 Mar 17;348:g2190. doi: 10.1136/bmj.g2190. (PMID: 24642804)
Contributed Indexing:
Keywords: HPV; PREVENTION; VACCINATION; WOMEN
Substance Nomenclature:
0 (Papillomavirus Vaccines)
Entry Date(s):
Date Created: 20140319 Date Completed: 20140626 Latest Revision: 20181202
Update Code:
20250114
DOI:
10.1136/sextrans-2013-051179
PMID:
24636998
Database:
MEDLINE

Weitere Informationen

Objectives: The U.K. human papilloma virus (HPV) vaccination programme requires 80% uptake to have a significant impact on cervical cancer rates. Uptake in the first three years of the programme was 66%. We report the results of a cross-sectional survey of young women attending sexual health services (SHS) in England, reviewing HPV vaccination uptake and prevalence of HPV-related risk factors.
Methods: An anonymous questionnaire surveyed women aged 13-19 attending 19 hospital-based and 13 community-based SHS across England, March-August 2011. Data were analysed using multiple logistic regression.
Results: 2247 questionnaires were completed. Compared with national data, respondents had higher smoking rates (48% vs. 14% of 15 year olds), coitarche under-16 (52% vs. 38%), previous sexually transmitted infections (STIs) (25% vs. 4%) and a higher proportion not in education, employment or training (NEETs) (8% vs. 2% of 16 year olds). Seventy-four per cent had been offered the vaccination, with significantly lower offer rates in London, non-white ethnicities, 17-19 year olds, NEETs, smokers and those with previous STIs (all p<0.05 in multivariate analysis). Sixty-five per cent of those offered, completed, with significantly lower completion rates in London, non-white ethnicities, 17-19 year olds, NEETs, smokers and those with previous STIs (all p<0.05 in multivariate analysis). Overall completion rate was 47%.
Conclusions: We observed lower vaccination offer and completion rates and higher prevalence of HPV-related risk factors compared with national data. The highest risk individuals were the least likely to have been offered or to have completed the course. This survey highlights an opportunity for primary prevention by routinely offering the HPV vaccine to eligible women attending SHS.
(Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.)